821794-92-7,
FMK,
1-[4-Amino-7-(3-hydroxypropyl)-5-(4-methylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-2-fluoroethanone,
CHEMBL515414,
1-(4-amino-7-(3-hydroxypropyl)-5-p-tolyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)-2-fluoroethanone,
1-(4-amino-7-(3-hydroxypropyl)-5-(p-tolyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)-2-fluoroethanone,
1-[4-amino-7-(3-hydroxypropyl)-5-(4-methylphenyl)pyrrolo[2,3-d]pyrimidin-6-yl]-2-fluoroethanone,
FMK (covalent),
RSK inhibitor Fmk,
AC1LD8U9,
FMK;RSK2 kinase inhibitor,
GTPL9358,
SCHEMBL12200837,
KS-00001DWT,
DTXSID40349344,
EX-A846,
BCP10804,
ZINC6718642,
3681AH,
BDBM50248765,
HY-52101A,
MFCD22417081,
AKOS027325130,
CS-0648,
QC-8903,
NCGC00386649-02,
fluoromethylketone-pyrrolopyrimidine scaffold,
FT-0700368,
A11423,
W-5913,
J-690355,
1-[4-Amino-5-(4-methylphenyl)-7-(3-hydroxypropyl)-7H-pyrrolo[2,3-d]pyrimidine-6-yl]-2-fluoroethanone,
1-[4-Amino-7-(3-hydroxypropyl)-5-(4-methylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-2-fluoroethan-1-one,
ethanone, 1-[4-amino-7-(3-hydroxypropyl)-5-(4-methylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-2-fluoro-,
Ethanone, 1-[4-amino-7-(3-hydroxypropyl)-5-(4-methylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-2-fluoro- (9CI),
nchembio859-comp1,
C18H19FN4O2,
IKLGYJACVCXYIL-UHFFFAOYSA-N,
CID644243,
A3420,
4-(tert-Butyl)-N-(2-methyl-3-(4-methyl-6-((4-(morpholine-4-carbonyl)phenyl)amino)-5-oxo-4,5-dihydropyrazin-2-yl)phenyl)benzamide,